SANTA CLARA, Calif.--(BUSINESS WIRE)--NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that five of its most recent medical and technical submissions have been accepted for publication in prominent peer-reviewed medical journals. These publications will present important clinical data supporting the accuracy and effectiveness of its CardioBip™ and Cardio3KG™ products.
